Mounjaro (tirzepatide) comes in six dose strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. Everyone starts at the lowest dose and works up gradually, with the maximum weekly dose capped at 15 mg for adults and 10 mg for pediatric patients aged 10 and older. Each strength is a once-weekly injection, and the step-up schedule is designed to give your body time to adjust.
The Standard Titration Schedule
Every patient begins at 2.5 mg once a week for four weeks. This starting dose isn’t meant to control blood sugar on its own. It exists purely to let your digestive system acclimate to the medication and reduce the chance of nausea and other gut-related side effects.
After those first four weeks, the dose increases to 5 mg once weekly. From there, if more blood sugar control (or weight loss) is needed, your prescriber can bump the dose up in 2.5 mg steps: from 5 mg to 7.5 mg, then 10 mg, 12.5 mg, and finally 15 mg. Each increase requires at least four weeks at the current dose before moving up. That means reaching the maximum 15 mg dose takes a minimum of about 20 weeks if you move up at every opportunity.
Not everyone needs to reach 15 mg. Many people find adequate results at 5 mg or 10 mg, and prescribers will often hold at whichever dose is working well rather than pushing higher.
How Each Dose Performs
Clinical trials show a clear dose-response pattern. In the SURPASS trials involving people with type 2 diabetes, average A1C reductions at 40 to 52 weeks were roughly 1.9 to 2.0 percentage points at 5 mg, 2.2 to 2.4 points at 10 mg, and 2.3 to 2.6 points at 15 mg. For context, dropping A1C by two full points can mean going from poorly controlled diabetes into a near-normal range for some patients.
On the weight loss side, a large trial (SURMOUNT-4) found that participants taking the maximum tolerated dose of 10 or 15 mg lost an average of 20.9% of their body weight over 36 weeks. That translates to roughly 45 to 50 pounds for someone starting at around 235 pounds. Lower doses still produce meaningful weight loss, but the higher doses consistently deliver more.
Side Effects Increase With Dose
The most common side effects are gastrointestinal: nausea, diarrhea, vomiting, and reduced appetite. A meta-analysis pooling data from over 3,000 patients at each dose level found that these effects track upward as the dose climbs. At 5 mg, about 15% of patients reported nausea. At 10 mg, that rose to roughly 21%, and at 15 mg, about 25%. Vomiting followed a similar pattern, affecting around 6% at the lowest therapeutic dose and climbing to about 11% at 15 mg.
Most of these symptoms are worst during the first few weeks after each dose increase and tend to ease over time. The gradual titration schedule exists specifically to soften this adjustment period. Severe gastrointestinal reactions are uncommon, occurring in about 0.4% to 1.3% of patients across dose levels in placebo-controlled trials. Mounjaro is not recommended for people with severe gastroparesis, a condition where the stomach empties abnormally slowly.
How Mounjaro Works Differently
Mounjaro activates two gut hormone receptors instead of one. Most similar medications (like semaglutide) target only the GLP-1 receptor, which helps regulate insulin release and appetite. Mounjaro also activates the GIP receptor. When both receptors are stimulated together, the insulin response is greater than activating either one alone, and the combination suppresses glucagon, a hormone that raises blood sugar, more effectively than either hormone does individually. This dual action is why Mounjaro tends to produce larger reductions in both blood sugar and body weight compared to single-receptor medications.
Practical Dosing Details
You inject Mounjaro once a week on the same day each week, though the specific day is flexible. You can change your injection day as long as at least 72 hours have passed since your last dose. Injection sites include the abdomen, thigh, or upper arm, and rotating the site with each injection helps prevent skin irritation.
If you miss a dose, take it as soon as you remember as long as it’s within four days of when it was due. If more than four days have passed, skip that dose and resume at your next scheduled time. Never take two doses in the same week. If you’ve missed two or more consecutive weeks, contact your prescriber before restarting, as you may need to re-titrate from a lower dose to avoid a surge of side effects.
Storage Requirements
Unused pens belong in the refrigerator at 2°C to 8°C (about 36°F to 46°F). If you need to travel or can’t refrigerate them, unused pens can stay at room temperature (up to 30°C or 86°F) for up to 30 days. Once you’ve used a pen, it can also be stored at room temperature for up to 30 days. Never freeze Mounjaro. If a pen has been frozen, discard it.
Pediatric Dosing
As of late 2025, Mounjaro gained approval for pediatric patients aged 10 and older with type 2 diabetes. The titration schedule is the same, starting at 2.5 mg and increasing in 2.5 mg steps every four weeks, but the maximum dose for this age group is 10 mg per week rather than the 15 mg allowed for adults.